Extended warfarin delays return of unprovoked pulmonary embolism

08.07.20151326
Adding an extra 18 months of warfarin therapy to the standard 6 months of anticoagulation delays the recurrence of venous thrombosis in patients who have a first episode of unprovoked pulmonary embolism.

FDA approves new treatment for HF

07.07.20151474
The FDA has approved a first-in-class angiotensin receptor-neprilysin inhibitor for the reduction of CV death and HF-related hospitalization among patients with HF and reduced ejection fraction, according to a press release.

Can venous thromboembolism navigate the prevention of cardiovascular complications?

06.07.20151314
Traditionally venous and arterial thrombosis has been viewed as two separate pathophysiological and clinical entities.

CHD linked to osteoporosis in older adults

03.07.20151595
Older adults with a history of coronary heart disease have a substantially lower cortical volumetric bone mineral density at the distal radius, putting them at risk for fracture, according to research in Osteoporosis International.

Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure

02.07.20151426
There are few prospective data available for establishing a standard diuretic administration regimen for patients with acute decompensated heart failure (ADHF).

New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint

01.07.20152451
The antithrombotic management of patients on oral anticoagulation (OAC), with either warfarin or non-vitamin K-antagonist oral anticoagulants (NOACs), undergoing percutaneous coronary intervention with stent (PCI-S) has been recently addressed in a joint European consensus document.

June 11, 2015 Scientific conference with international participation “PREVENTION 2015” was held in Moscow

30.06.20151319
Opening ceremony started with greetings to all participants.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.